Brainstorm Cell Net Worth

Brainstorm Cell Net Worth Breakdown

  BCLI
The net worth of Brainstorm Cell Therapeutics is the difference between its total assets and liabilities. Brainstorm Cell's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Brainstorm Cell's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Brainstorm Cell's net worth can be used as a measure of its financial health and stability which can help investors to decide if Brainstorm Cell is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Brainstorm Cell Therapeutics stock.

Brainstorm Cell Net Worth Analysis

Brainstorm Cell's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Brainstorm Cell's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Brainstorm Cell's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Brainstorm Cell's net worth analysis. One common approach is to calculate Brainstorm Cell's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Brainstorm Cell's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Brainstorm Cell's net worth. This approach calculates the present value of Brainstorm Cell's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Brainstorm Cell's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Brainstorm Cell's net worth. This involves comparing Brainstorm Cell's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Brainstorm Cell's net worth relative to its peers.

Enterprise Value

150.13 Million

To determine if Brainstorm Cell is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Brainstorm Cell's net worth research are outlined below:
Brainstorm Cell Ther generated a negative expected return over the last 90 days
Brainstorm Cell Ther has high historical volatility and very poor performance
Brainstorm Cell Ther may become a speculative penny stock
Brainstorm Cell Ther has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (17.19 M) with profit before overhead, payroll, taxes, and interest of 0.
Brainstorm Cell Therapeutics currently holds about 12.24 M in cash with (20.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34.
Brainstorm Cell Ther has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Acquisition by Arbel Irit of 25333 shares of Brainstorm Cell at 0.75 subject to Rule 16b-3
Brainstorm Cell uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Brainstorm Cell Therapeutics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Brainstorm Cell's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Brainstorm Cell's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Brainstorm Cell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Brainstorm Cell Therapeutics backward and forwards among themselves. Brainstorm Cell's institutional investor refers to the entity that pools money to purchase Brainstorm Cell's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Two Sigma Securities, Llc2024-06-30
102 K
Tower Research Capital Llc2024-06-30
86.6 K
Virtu Financial Llc2024-06-30
49.6 K
Group One Trading, Lp2024-06-30
46.8 K
Morgan Stanley - Brokerage Accounts
37 K
Wells Fargo & Co2024-06-30
28.8 K
Creative Planning Inc2024-06-30
20.9 K
Janney Montgomery Scott Llc2024-06-30
20.5 K
Jane Street Group Llc2024-06-30
19.8 K
Armistice Capital, Llc2024-06-30
7.9 M
Vanguard Group Inc2024-06-30
1.5 M
Note, although Brainstorm Cell's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Brainstorm Cell's market capitalization trends

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.92 M.

Market Cap

150.67 Million

Project Brainstorm Cell's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(4.09)(4.29)
Return On Capital Employed 5.97  6.27 
Return On Assets(4.09)(4.29)
Return On Equity 3.54  3.72 
When accessing Brainstorm Cell's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Brainstorm Cell's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Brainstorm Cell's profitability and make more informed investment decisions.

Evaluate Brainstorm Cell's management efficiency

Brainstorm Cell Ther has return on total asset (ROA) of (1.782) % which means that it has lost $1.782 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.219) %, meaning that it created substantial loss on money invested by shareholders. Brainstorm Cell's management efficiency ratios could be used to measure how well Brainstorm Cell manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Brainstorm Cell's Return On Capital Employed is increasing as compared to previous years. The Brainstorm Cell's current Return On Equity is estimated to increase to 3.72, while Return On Tangible Assets are projected to decrease to (4.29). The current Total Assets is estimated to decrease to about 4 M. The current Non Current Assets Total is estimated to decrease to about 1.6 M
Last ReportedProjected for Next Year
Book Value Per Share(0.11)(0.11)
Tangible Book Value Per Share(0.11)(0.11)
Enterprise Value Over EBITDA(10.37)(10.89)
Price Book Value Ratio(36.27)(38.09)
Enterprise Value Multiple(10.37)(10.89)
Price Fair Value(36.27)(38.09)
Enterprise Value158 M150.1 M
The decision-making processes within Brainstorm Cell are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Return On Equity
(11.22)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Brainstorm Cell insiders, such as employees or executives, is commonly permitted as long as it does not rely on Brainstorm Cell's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Brainstorm Cell insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Brainstorm Cell time-series forecasting models is one of many Brainstorm Cell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Brainstorm Cell's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Brainstorm Cell Earnings per Share Projection vs Actual

Brainstorm Cell Corporate Management

Antal PearlLendnerVP CounselProfile
Daniel OffenChief AdvisorProfile
Ibrahim MDExecutive OfficerProfile
Mary TurnerSenior AffairsProfile
Netta BlondheimShragaSenior DevelopmentProfile
Stacy LindborgCoChief OfficerProfile
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.45)
Return On Assets
(1.78)
Return On Equity
(11.22)
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.